Company Filing History:
1 out of 832,843 Years Active: 2002
Title: Riccardo Vigneri: Innovator in Genetic Research
Introduction
Riccardo Vigneri is a prominent inventor based in Catania, Italy. He has made significant contributions to the field of genetic research, particularly in understanding insulin resistance. His work has implications for drug development and genetic predisposition to metabolic disorders.
Latest Patents
Vigneri holds a patent for "Polymorphic human PC-1 sequences associated with insulin resistance." This patent describes a novel polymorphism in the human PC-1 gene, which is linked to an increased risk of developing insulin resistance. The polymorphism affects both heterozygous and homozygous carriers of the allele. The subject nucleic acids and fragments, along with encoded polypeptides and antibodies specific for the polymorphic amino acid sequence, are valuable for determining genetic predisposition to insulin resistance. The encoded protein is also useful in drug screening for compositions that influence PC-1 activity and insulin receptor activity or expression.
Career Highlights
Throughout his career, Vigneri has focused on the genetic factors contributing to insulin resistance. His research has provided insights that could lead to better therapeutic strategies for managing metabolic diseases. His innovative approach has garnered attention in the scientific community.
Collaborations
Vigneri has collaborated with notable researchers, including Ira D Goldfine and Vincenzo Trischitta. These partnerships have enhanced the depth and impact of his research in the field of genetics.
Conclusion
Riccardo Vigneri's work in genetic research, particularly regarding insulin resistance, showcases his innovative spirit and dedication to advancing medical science. His contributions are paving the way for future developments in understanding and treating metabolic disorders.